Artiva Biotherapeutics, Inc. (ARTV) vs Fennec Pharmaceuticals Inc. (FENC)
A side-by-side comparison of Artiva Biotherapeutics, Inc. and Fennec Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTV
Artiva Biotherapeutics, Inc.
$7.28HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
FENC
Fennec Pharmaceuticals Inc.
$10.27HealthcareDelayed quote: Oct 6, 2026, 11:58 AM EDT
Total return — ARTV vs FENC
growth of $100 · dividends reinvested · last 2yARTV -40.6% (-22.9%/yr)FENC +67.5% (+29.4%/yr)FENC compounded faster over this window
ARTV FENC
ARTV vs FENC: by the numbers
- •FENC is the larger company ($357M vs $356M market cap).
- •Both run net losses; ARTV's is the smaller (0.00% vs -5.49% net margin).
Metrics side by side
Valuation
| Metric | ARTV | FENC |
|---|---|---|
| Forward P/E | N/A | 36.23 |
| P/S ratio | N/A | 6.02 |
| P/B ratio | 1.02 | 8.40 |
Profitability
| Metric | ARTV | FENC |
|---|---|---|
| Gross margin | 0.00% | 93.73% |
| Operating margin | 0.00% | -14.22% |
| Net margin | 0.00% | -5.49% |
| ROE | -26.14% | -7.66% |
| ROIC | -27.16% | -1.84% |
Growth (annualized)
| Metric | ARTV | FENC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 222.46% |
| Total return CAGR (5Y) | N/A | 2.45% |
Go deeper
Dig into the metrics
Artiva Biotherapeutics ROEFennec Pharmaceuticals ROEArtiva Biotherapeutics operating marginFennec Pharmaceuticals operating marginArtiva Biotherapeutics revenue growthFennec Pharmaceuticals revenue growthArtiva Biotherapeutics free cash flowFennec Pharmaceuticals free cash flow
Artiva Biotherapeutics & Fennec Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.